Financhill
Back

Blueprint Medicines Quote, Financials, Valuation and Earnings

Blueprint Medicines Price Quote

$90.24
+0.05 (+1.47%)
(Updated: December 21, 2024 at 5:18 AM ET)

Blueprint Medicines Key Stats

Sell
40
Blueprint Medicines (BPMC) is a Sell

Day range:
$87.99 - $90.99
52-week range:
$72.24 - $121.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.02
P/B ratio:
18.3%

Volume:
1.2M
Avg. volume:
645.7K
1-year change:
7.22%
Market cap:
$5.7B
Revenue:
$249.4M
EPS:
$-2.11

How Much Does Blueprint Medicines Make?

Data Unavailable

Is Blueprint Medicines Growing As A Company?

Data Unavailable

Blueprint Medicines Stock Price Performance

What Is Blueprint Medicines 52-Week High & Low?

Blueprint Medicines Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Blueprint Medicines?

Data Unavailable

Is Blueprint Medicines Cash Flow Positive?

Data Unavailable

Blueprint Medicines Return On Invested Capital

Data Unavailable

Blueprint Medicines Earnings Date & Stock Price

Blueprint Medicines Competitors

  • Who Are Blueprint Medicines's Competitors?
    Below is a list of companies who compete with Blueprint Medicines or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • PTC Therapeutics Inc (PTCT)
    • Regeneron Pharmaceuticals Inc (REGN)
    • SpringWorks Therapeutics Inc (SWTX)
    • Vertex Pharmaceuticals Inc (VRTX)

Blueprint Medicines Dividend Yield

Data Unavailable

Blueprint Medicines Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.41%
Revenue: 126.61% 0.56%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 125.58
Upside from Last Price: 39.24%

Major Shareholders

Data Unavailable